Company Filing History:
Years Active: 2015-2018
Title: **Innovator Spotlight: Vidya B Pai, Jr. from Rockville, MD**
Introduction
Vidya B Pai, Jr. is a prominent inventor based in Rockville, Maryland, recognized for his significant contributions to the field of immunology. With two patents to his name, his work focuses particularly on the development of vaccines, specifically targeting dengue virus. His innovative approaches are paving the way for safer and more effective treatments.
Latest Patents
One of Vidya's latest patents is for a recombinant subunit dengue virus vaccine. This invention includes immunogenic compositions designed for administration to human subjects. The vaccine compositions comprise recombinantly produced monomeric and/or dimeric forms of truncated dengue virus envelope glycoprotein. These formulations, when combined with an adjuvant and a pharmaceutically acceptable carrier, are shown to induce balanced tetravalent immune responses. In preferred embodiments, the DEN4 protein component is a dimeric form of DEN4. These compositions aim for broad usability, being acceptable for the general population, including immunosuppressed, immunocompromised, and immunosenescent individuals. Additionally, methods for inducing a protective immune response in human patient populations through the administration of these compositions are also covered.
Career Highlights
Vidya B Pai, Jr. is currently affiliated with Merck Sharp & Dohme Corporation, a leading company in the pharmaceutical industry. His career reflects a commitment to advancing medical science through innovative solutions and patentable inventions.
Collaborations
Throughout his career, Vidya has collaborated with esteemed colleagues, including Beth-Ann Griswold Coller and D. Elliot Parks. These collaborative efforts exemplify the importance of teamwork in achieving groundbreaking advancements in science and healthcare.
Conclusion
Vidya B Pai, Jr.'s work exemplifies how dedicated individuals can significantly impact public health through innovation in vaccine development. His contributions not only further scientific knowledge but also facilitate the creation of medical solutions that can save lives across diverse populations.